Uterine Muscle Relaxant
Uterine muscle relaxant (UMR) is a medication that is sometimes used in the context of in vitro fertilization (IVF) to help prevent premature uterine contractions and improve the chances of successful embryo implantation. It is a synthetic peptide that acts as an antagonist of oxytocin, which is a hormone responsible for stimulating uterine contractions.
By blocking the effects of oxytocin, UMR can help relax the uterine muscle and reduce the occurrence of contractions during and after embryo transfer. This relaxation is aimed at creating a more favorable environment for embryo implantation and reducing the risk of embryo expulsion or displacement.
However, it’s important to note that the use of UMR in IVF is not a routine practice and its efficacy in improving IVF success rates is still a subject of debate. The available evidence regarding the benefits of UMR in IVF is limited and conflicting.
Some studies have suggested potential benefits of UMR in reducing uterine contractions and improving pregnancy rates, particularly in specific cases where uterine contractions have been observed during embryo transfer. Other studies have not found significant improvements in IVF outcomes with the use of UMR.